Sonosemi Medical Co., Ltd. abbreviated as "Sonosemi Medical" was established in April 2020, with its headquarters located in Shenzhen, the frontier of China's technological innovation. It is a national high-tech enterprise focusing on technological innovation and industrialization in the field of vascular active interventional diagnosis and treatment. As a domestic provider and pioneer of solutions in this field, Sonosemi Medical has always stood at the forefront of the industry and clinical needs, committed to providing greener, more precise, and safer product solutions. The company adopts a dual-wheel drive model of "clinical needs + technological innovation," relying on an enterprising innovative spirit and professional technical R&D strength, employing, an integrated research-production-sales and open-collaborative industrial strategy. It has taken the lead in launching innovative products such as the coronary intravascular lithotripsy system, intracardiac echocardiography system, peripheral intravascular lithotripsy system, and other innovative products, gradually building a full-scenario solution for vascular interventional diagnosis and treatment, and striving to create greater value for doctors and patients.